Diammonium Glycyrrhizinate Attenuates Aβ(1-42) -Induced Neuroinflammation and Regulates MAPK and NF-κB Pathways In Vitro and In Vivo.

CONCLUSIONS: DG protects Aβ(1-42) -induced AD models in vitro and in vivo through reducing activation of microglia and inflammation, which may be involved in MAPK and NF-κB pathways. PMID: 23279783 [PubMed - in process]
Source: CNS Neuroscience and Therapeutics - Category: Neuroscience Authors: Tags: CNS Neurosci Ther Source Type: research